Nextgen Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 9.90 M
- Paid Up Capital ₹ 9.90 M
- Company Age 14 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 4.88%
- Profit Growth -4.01%
- Ebitda 8.06%
- Net Worth 19.75%
- Total Assets 12.47%
About Nextgen Healthcare India
Nextgen Healthcare India Private Limited (NHIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 24 January 2011 and has a history of 14 years. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Quality Systems India Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.90 M and a paid-up capital of Rs 9.90 M, as per Ministry of Corporate Affairs (MCA) records.
Chandradip Dass, Jeffrey Linton, and Srinivas Velamoor serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85100KA2011FTC056781
-
Company No.
056781
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
24 Jan 2011
-
Date of AGM
13 Nov 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Nextgen Healthcare India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandradip Dass
|
Managing Director | 27-Jul-2017 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jeffrey Linton
|
Director | 30-Nov-2023 | Current |
| Srinivas Velamoor | Director | 06-Aug-2024 | Current |
Financial Performance of Nextgen Healthcare India.
Nextgen Healthcare India Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.88% increase. The company also saw a slight decrease in profitability, with a 4.01% decrease in profit. The company's net worth Soared by an impressive increase of 19.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nextgen Healthcare India?
In 2022, Nextgen Healthcare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nextgen Healthcare India?
Nextgen Healthcare India has a workforce of 715 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nextgen Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nextgen Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
